NextPlat NXPL
NASDAQ NXPL
$9.13 -0.30 (-3.18%)
At close: Sep 4, 2026 · 4:00 PM EDT

NextPlat (NXPL) Other Non-Current Assets (2015 - 2026)

NextPlat's (NXPL) quarterly Other Non-Current Assets came in at $37000.0 in Q2 2026, down 57.47% year-over-year from $87000.0 in Q2 2025, and down 93.73% quarter-over-quarter from $590000.0 in Q1 2026.

Analysis

NextPlat (NXPL) Other Non-Current Assets (2015 - 2026) Analysis & Trends

NextPlat (NXPL) has reported Other Non-Current Assets for 8 consecutive years, with $37000.0 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Other Non-Current Assets fell 57.47% year-over-year to $37000.0 in Q2 2026; TTM through Jun 2026 was $37000.0, a 57.47% decrease from a year earlier, with the FY2025 full-year figure at $37000.0, down 60.64% from the prior year.
  • Other Non-Current Assets was $37000.0 for Q2 2026 at NextPlat, down from $590000.0 in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $6.1 million in Q1 2023 and troughed at $37000.0 in Q4 2025.
  • A 5-year average of $428310.7 and a median of $61000.0 in 2023 frame the typical range for Other Non-Current Assets.
  • Across the five-year window, Other Non-Current Assets soared 12241.56% in 2023 and plunged 99.0% in 2024, its largest moves.
  • Over 5 years, Other Non-Current Assets stood at $49000.0 in 2022, then advanced by 24.49% to $61000.0 in 2023, then jumped by 54.1% to $94000.0 in 2024, then tumbled by 60.64% to $37000.0 in 2025, then changed by 0.0% to $37000.0 in 2026.
  • The last three Other Non-Current Assets figures came in at $37000.0 (Q2 2026), $590000.0 (Q1 2026), and $37000.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn 1.79 Bn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn 1.06 Bn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn 11.74 Mn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn 80.67 Mn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn 358.00 Mn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn 11.62 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn 14.42 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn 33.39 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn 666,000.00
10 NextPlat 24.77 Mn 12.93 Mn 4.69 Mn 37,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 37,000.00
Mar 31, 2026 590,000.00
Dec 31, 2025 37,000.00
Sep 30, 2025 79,000.00
Jun 30, 2025 87,000.00
Mar 31, 2025 94,000.00
Dec 31, 2024 94,000.00
Sep 30, 2024 94,000.00
Jun 30, 2024 66,000.00
Mar 31, 2024 61,000.00
Dec 31, 2023 61,000.00
Sep 30, 2023 49,135.00
Jun 30, 2023 49,373.00
Mar 31, 2023 6.13 Mn
Dec 31, 2022 49,000.00
Sep 30, 2022 42,424.00
Jun 30, 2022 42,424.00
Mar 31, 2022 49,650.00
Dec 31, 2021 147,510.00
Sep 30, 2021 38,706.00